Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

55.65
-0.3700-0.66%
Post-market: 55.650.00000.00%19:30 EDT
Volume:3.06M
Turnover:169.31M
Market Cap:9.25B
PE:-15.99
High:55.77
Open:55.75
Low:54.91
Close:56.02
52wk High:86.74
52wk Low:50.01
Shares:166.18M
Float Shares:161.92M
Volume Ratio:0.73
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:21.03
PE(LYR):-23.37

Loading ...

Novartis announces Phase 3 pelacarsen study did not meet primary endpoint

TIPRANKS
·
Sep 05

Ionis-Novartis Heart Drug Misses Main Goal of Late-Stage Trial

Reuters
·
Sep 05

Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint

Dow Jones
·
Sep 05

Ionis Pharmaceuticals: Buy Rating Backed by FDA Approval of Zanvastro and Strengthened Neurology Pipeline Upside

TIPRANKS
·
Sep 05

Movement Alert|Ionis Pharmaceuticals Falls 9.43% in After-Hours Trading, FDA Approval of Alexander Disease Drug Triggers Sell-the-News Reaction

Market Focus
·
Sep 05

Ionis Pharmaceuticals (IONS) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Sep 05

This Biotech Wins a Big FDA Approval. Why Wall Street is Shrugging.

Dow Jones
·
Sep 05

Analysts’ Opinions Are Mixed on These Healthcare Stocks: cbdMD (YCBD) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Sep 04

Ionis Pharmaceuticals' Zanvastro Approval Sets Path for Independent Neurology Business, Oppenheimer Says

MT Newswires Live
·
Sep 04

Ionis Pharmaceuticals Exec Says Zanvastro Will be Available at List Price of $285,000 Per Dose

THOMSON REUTERS
·
Sep 04

U.S. Stocks on the MOVE-Lululemon Athletica, Adobe, Ionis Pharmaceuticals

Reuters
·
Sep 04

Ionis Pharmaceuticals (IONS) Receives a Hold from BMO Capital

TIPRANKS
·
Sep 04

Ionis Pharmaceuticals Price Target Maintained with a $115.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 04

Ionis Pharma up After US FDA Approves Rare Brain Disorder Treatment

Reuters
·
Sep 04

Ionis Pharmaceuticals Gets FDA Approval for Alexander Disease Treatment

MT Newswires Live
·
Sep 04

U.S. Research Roundup-Ciena Corp, Docusign, Snowflake

Reuters
·
Sep 04

Ionis Pharmaceuticals, Inc. : Jefferies Cuts Target Price to $88 from $90

THOMSON REUTERS
·
Sep 04

US FDA Approves Ionis Pharma's Therapy to Treat Rare Genetic Disorder

Reuters
·
Sep 04

FDA: Approves Zanvastro (Zilganersen) Injection for Treatment of Alexander Disease in Pediatric and Adult Patients

THOMSON REUTERS
·
Sep 04

Movement Alert|Ionis Pharmaceuticals Falls 5.06% in Regular Trading, Trading at $58.215

Market Focus
·
Sep 04